Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,798Revenue $M14,237Net Margin (%)30.3Z-Score16.9
Enterprise Value $M119,526EPS $1.6Operating Margin %38.1F-Score8
P/E(ttm))27.0Cash Flow Per Share $0Pre-tax Margin (%)39.0Higher ROA y-yY
Price/Book18.410-y EBITDA Growth Rate %19.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales8.25-y EBITDA Growth Rate %22.3Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %6.1ROA % (ttm)38.6Higher Current Ratio y-yN
Dividend Yield %1.4Insider Buy (3m)0ROE % (ttm)68.5Less Shares Outstanding y-yY
Payout Ratio %33.0Shares Outstanding M2,750ROI % (ttm)69.1Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVORuane Cunniff 2014-09-30 Reduce-0.02%$43.9 - $49.03
($46)
$ 44.29-4%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 44.290%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 44.294%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.886
($34.84)
$ 44.2927%Add 58.71%62,194
NVORuane Cunniff 2013-06-30 Buy 0.04%$30.11 - $35.33
($33.29)
$ 44.2933%New holding, 34640 sh.34,640
NVOMario Gabelli 2013-03-31 Reduce$32.24 - $38.86
($34.93)
$ 44.2927%Reduce -60.32%1,734
NVOJohn Hussman 2012-09-30 Sold Out -0.01%$28.83 - $32.15
($30.65)
$ 44.2944%Sold Out0
NVOKen Fisher 2012-06-30 Add1.01%$25.98 - $30.38
($28.44)
$ 44.2956%Add 519.97%2,786,828
NVOJohn Hussman 2012-03-31 Reduce$23.09 - $28.94
($24.82)
$ 44.2978%Reduce -40%3,000
NVOMario Gabelli 2011-12-31 Add$18.92 - $23.05
($21.5)
$ 44.29106%Add 66.87%5,590
NVOJohn Hussman 2011-09-30 Buy 0.01%$19.46 - $25.45
($22.27)
$ 44.2999%New holding, 5000 sh.5,000
NVOKen Fisher 2011-06-30 Add0.06%$23.4 - $26.29
($24.91)
$ 44.2978%Add 68.56%456,434
NVOMario Gabelli 2011-06-30 Reduce$23.4 - $26.29
($24.91)
$ 44.2978%Reduce -21.18%3,350
NVOJohn Keeley 2011-06-30 Sold Out -0.01%$23.4 - $26.29
($24.91)
$ 44.2978%Sold Out0
NVOKen Fisher 2011-03-31 Buy 0.09%$22.16 - $25.59
($23.8)
$ 44.2986%New holding, 270785 sh.270,785
NVOJohn Keeley 2010-12-31 Buy 0.01%$18.2 - $22.43
($20.77)
$ 44.29113%New holding, 2780 sh.2,780
NVOMario Gabelli 2010-09-30 Reduce$16.23 - $19.85
($17.64)
$ 44.29151%Reduce -28.77%4,420
NVOVanguard Health Care Fund 2010-09-30 Sold Out -0.19%$16.23 - $19.85
($17.64)
$ 44.29151%Sold Out0
NVOMario Gabelli 2010-06-30 Reduce$14.8 - $17.06
($15.97)
$ 44.29177%Reduce -56.26%6,205
NVOVanguard Health Care Fund 2010-06-30 Reduce-0.08%$14.8 - $17.06
($15.97)
$ 44.29177%Reduce -42.86%400,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVO Tom Gayner 2014-09-301,075,0000.041.4
NVO Ken Fisher 2014-09-3013,385,9130.491.4-2.59%
NVO Mario Gabelli 2014-09-306,72000-11.81%
NVO Ruane Cunniff 2014-09-3075,64200.02-52.87%
Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

    Quarterly/Annual Reports about NVO:

      News about NVO:

      Articles On GuruFocus.com
      Examining The Three Largest Guru Portfolios Oct 24 2014 
      Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
      Insider Buys at Halozyme Look to Improve Stock Outlook Sep 18 2014 
      Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
      Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Sep 02 2014 
      Guru Stocks at 52-Week Lows: CHL, TM, SNY, NVO, TSM Aug 23 2014 
      GAMCO CIO Howard Ward on Reliable Consumer Stock Ideas Apr 09 2014 
      Assessing the New Boss at National Oilwell Varco Mar 31 2014 
      Amgen Inc: As Good as It Gets? Feb 20 2014 
      Shire PLC: Time to Panic? Feb 07 2014 

      More From Our Partners
      Playing Defense All Around The World Nov 20 2014 - SEEKINGALPHA

      More From Other Websites
      Victoza® receives positive CHMP opinion for use in adults with type 2 diabetes and moderate renal... Nov 21 2014
      Sanofi's Bullish Pipeline Forecast Underwhelms Street Nov 20 2014
      Share repurchase programme Nov 17 2014
      Novo Nordisk second best in the world at providing access to medicine Nov 17 2014
      Media Release - Top 100 Employer Nov 04 2014
      New phase 3a data demonstrate that 9 out of 10 adults with obesity lost weight with liraglutide 3 mg... Nov 04 2014
      Novo Nordisk's Earnings Rise in Q3, 2014 Outlook Narrowed Nov 03 2014
      Novo Nordisk and Roche Diabetes Care launch new treatment option to simplify insulin pump therapy Nov 03 2014
      Novo Nordisk: City of Houston and Novo Nordisk partner to lead fight against urban diabetes epidemic Nov 03 2014
      Trading in Novo Nordisk shares by board members, executives and associated persons on 30 October... Oct 31 2014
      Novo Nordisk invests DKK 750 million in new laboratories for diabetes research in Denmark Oct 31 2014
      Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% Oct 31 2014
      Market Thorns, Roses, All Time Highs, and ETF All Time Highs... Oct 30 2014
      Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints Oct 30 2014
      Alcatel-Lucent rallies, Lufthansa slides: Europe’s big stock movers Oct 30 2014
      European stocks climb for third straight day Oct 30 2014
      [$$] Novo Nordisk Reassures Investors Oct 30 2014
      Sanofi Axes CEO, Hit By Multiple Downgrades Oct 29 2014
      Sanofi fires CEO Oct 29 2014
      Share repurchase programme Oct 29 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Gintaras58
      ReplyGintaras58 - 8 months ago
      few excellent prducts to come soon
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK